✦ LIBER ✦

Development and validation of an in vitro–in vivo correlation (IVIVC) model for propranolol hydrochloride extended-release matrix formulations

✍ Scribed by Cheng, Chinhwa; Wu, Pao-Chu; Lee, Hsin-Ya; Hsu, Kuang-Yang

Book ID: 122655118
Publisher: Elsevier
Year: 2014
Tongue: Chinese
Weight: 464 KB
Volume: 22
Category: Article
ISSN: 1021-9498
DOI: 10.1016/j.jfda.2013.09.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and validation of an in vitr

Development and validation of an in vitro–in vivo correlation for buspirone hydrochloride extended release tablets

✍ Sevgi Takka; Adel Sakr; Arthur Goldberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 692 KB

Development and Internal Validation of a

Development and Internal Validation of an In Vitro-in Vivo Correlation for a Hydrophilic Metoprolol Tartrate Extended Release Tablet Formulation

✍ Natalie D. Eddington; Patrick Marroum; Ramana Uppoor; Ajaz Hussain; Larry Augsbu 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 625 KB

Development of an Extended-Release Formu

Development of an Extended-Release Formulation of Capecitabine Making Use of In Vitro-In Vivo Correlation Modelling

✍ Meulenaar, Jelte; Keizer, Ron J.; Beijnen, Jos H.; Schellens, Jan H. M.; Huitema 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Bioavailability and In-vitro/in-vivo Cor

Bioavailability and In-vitro/in-vivo Correlation for Propranolol Hydrochloride Extended-release Bead Products Prepared Using Aqueous Polymeric Dispersions

✍ Gurvinder Singh Rekhi; Sunil S. Jambhekar 📂 Article 📅 1996 🏛 Pharmaceutical Press 🌐 English ⚖ 853 KB

Once-a-day extended-release dosage form

Once-a-day extended-release dosage form of divalproex sodium III: Development and validation of a Level A in vitro–in vivo correlation (IVIVC)

✍ Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G. Richard Granneman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Defining a quantitative and reliable relationship between in vitro drug release and in vivo absorption is highly desired for rational development, optimization, and evaluation of controlled-release dosage forms and manufacturing process. During the development of a once-daily extended-release (ER) t

Evaluation of “external” predictability

Evaluation of “external” predictability of an in vitro–in vivo correlation for an extended-release formulation containing metoprolol tartrate

✍ H. Mahayni; G. S. Rekhi; R. S. Uppoor; P. Marroum; A. S. Hussain; L. L. Augsburg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views